Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06216665 · ClinicalTrials.gov registry record · NA
Effect of Pulsatile Hormone Administration on Insulin Action
A NA study of Insulin Sensitivity, sponsored by Pennington Biomedical Research Center.
- Recruiting
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT06216665 is a NA study of Insulin Sensitivity that is actively recruiting participants, run by Pennington Biomedical Research Center. The registered enrollment target is 12 participants, below the 72-participant average among 29 other Insulin Sensitivity trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06216665, a NA study of Insulin Sensitivity, is actively recruiting participants, sponsored by Pennington Biomedical Research Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
In humans, insulin is secreted in pulses from the pancreatic beta-cells, and these oscillations help to maintain fasting plasma glucose levels within a narrow normal range. Given the fluctuations in insulin concentrations, oscillations enhance precision of control. The hyperinsulinemic euglycemic clamp test (clamp) involves a continuous infusion of insulin and is the gold standard for measuring insulin sensitivity. In this study, insulin sensitivity measured using the standard clamp will be compared with a clamp in which the same total amount of insulin as the standard clamp is infused every five minutes instead of continuously.
Conditions Studied
Interventions
- OTHER Continuous Insulin administration during hyperinsulinemic euglycemic clamp test
- OTHER Pulsatile Insulin administration during hyperinsulinemic euglycemic clamp test
Study Locations (1)
Louisiana
- Pennington Biomedical Research Center - Baton Rouge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2024-03-04 |
| Est. Completion | 2025-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06216665
The ClinicalTrials.gov registry entry for NCT06216665 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 72-participant average among 29 other Insulin Sensitivity trials with a reported enrollment target (83% lower). The listed sponsor is Pennington Biomedical Research Center, which has 258 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Insulin Sensitivity appearing as the primary indexed condition, and to 2 interventions - of which Continuous Insulin administration during hyperinsulinemic euglycemic clamp test is the first listed.
NCT06216665 reports 1 study location spanning 1 distinct geographic area - top geographies include Louisiana.
Frequently Asked Questions
What is clinical trial NCT06216665 about?
NCT06216665 is a clinical study titled "Effect of Pulsatile Hormone Administration on Insulin Action". In humans, insulin is secreted in pulses from the pancreatic beta-cells, and these oscillations help to maintain fasting plasma glucose levels within a narrow normal range. Given the fluctuations in insulin concentrations, oscillations enhance precision of control. The hyperinsulinemic euglycemic cl...
What is the current status of trial NCT06216665?
This trial is currently recruiting. It is a NA study. The enrollment target is 12 participants. The study started on 2024-03-04. Estimated completion is 2025-12.
What conditions does trial NCT06216665 study?
This clinical trial studies the following conditions: Insulin Sensitivity.
What interventions are being tested in trial NCT06216665?
The interventions under investigation include: Continuous Insulin administration during hyperinsulinemic euglycemic clamp test (OTHER), Pulsatile Insulin administration during hyperinsulinemic euglycemic clamp test (OTHER).
Who is sponsoring clinical trial NCT06216665?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06216665 being conducted?
This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insulin Sensitivity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling
RECRUITING · NA
-
Countermeasures to Circadian Misalignment
RECRUITING · NA
-
Mechanisms of Ultrasound Neuromodulation Effects in Diabetes
RECRUITING · NA
-
Effect of Physiologic Insulin Administration on Insulin Sensitivity and Cognition
RECRUITING · NA
-
Obesity, Insulin Resistance, and PASC: Persistent SARS-CoV-2
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.